Latest filing published 06 Dec 2021 for PFIZER INC, €2.0M.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Alexander R. Mackenzie: trading record in brief
All filings by Alexander R. Mackenzie on record concern Pfizer Inc, in the capacity of chief executive. Between 7 December 2016 and 2 December 2021, the trades on record add up to 67 filings.
Every open-market trade on record is a sale: 38 sales worth €6.1M. The rest of the record consists of 24 share grants and 5 option exercises. 2021 to date brings no purchases and 1 sale.
The latest filing, published on 6 December 2021, reports an open-market sale of €2.0M in Pfizer Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Alexander R. Mackenzie
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 41,360 shares@ US$54.26100.0% of flowCommon StockSEC:0001225208-21-014513:0
1 of 1 declaration
